Health Risks Associated with Long-Term Finasteride and Dutasteride Use: It's Time to Sound the Alarm
- PMID: 32202088
- PMCID: PMC7308241
- DOI: 10.5534/wjmh.200012
Health Risks Associated with Long-Term Finasteride and Dutasteride Use: It's Time to Sound the Alarm
Abstract
5α-dihydrotestosterone (5α-DHT) is the most potent natural androgen. 5α-DHT elicits a multitude of physiological actions, in a host of tissues, including prostate, seminal vesicles, hair follicles, skin, kidney, and lacrimal and meibomian glands. However, the physiological role of 5α-DHT in human physiology, remains questionable and, at best, poorly appreciated. Recent emerging literature supports a role for 5α-DHT in the physiological function of liver, pancreatic β-cell function and survival, ocular function and prevention of dry eye disease and kidney physiological function. Thus, inhibition of 5α-reductases with finasteride or dutasteride to reduce 5α-DHT biosynthesis in the course of treatment of benign prostatic hyperplasia (BPH) or male pattern hair loss, known as androgenetic alopecia (AGA) my induces a novel form of tissue specific androgen deficiency and contributes to a host of pathophysiological conditions, that are yet to be fully recognized. Here, we advance the concept that blockade of 5α-reductases by finasteride or dutasteride in a mechanism-based, irreversible, inhabitation of 5α-DHT biosynthesis results in a novel state of androgen deficiency, independent of circulating testosterone levels. Finasteride and dutasteride are frequently prescribed for long-term treatment of lower urinary tract symptoms in men with BPH and in men with AGA. This treatment may result in development of non-alcoholic fatty liver diseases (NAFLD), insulin resistance (IR), type 2 diabetes (T2DM), dry eye disease, potential kidney dysfunction, among other metabolic dysfunctions. We suggest that long-term use of finasteride and dutasteride may be associated with health risks including NAFLD, IR, T2DM, dry eye disease and potential kidney disease.
Keywords: 5-alpha reductase inhibitors; Diabetes mellitus; Dry eye syndromes; Hypogonadism; Kidney diseases; Non-alcoholic fatty liver disease.
Copyright © 2020 Korean Society for Sexual Medicine and Andrology.
Conflict of interest statement
The author has nothing to disclose.
Figures






Comment in
-
Bone Health Risks Associated with Finasteride and Dutasteride Long-Term Use.World J Mens Health. 2021 Apr;39(2):389-390. doi: 10.5534/wjmh.200138. Epub 2020 Nov 26. World J Mens Health. 2021. PMID: 33663032 Free PMC article. No abstract available.
Similar articles
-
Negative Impact of Testosterone Deficiency and 5α-Reductase Inhibitors Therapy on Metabolic and Sexual Function in Men.Adv Exp Med Biol. 2017;1043:473-526. doi: 10.1007/978-3-319-70178-3_22. Adv Exp Med Biol. 2017. PMID: 29224108 Review.
-
Dihydrotestosterone and the concept of 5alpha-reductase inhibition in human benign prostatic hyperplasia.World J Urol. 2002 Apr;19(6):413-25. doi: 10.1007/s00345-002-0248-5. World J Urol. 2002. PMID: 12022710 Review.
-
Dihydrotestosterone and the concept of 5alpha-reductase inhibition in human benign prostatic hyperplasia.Eur Urol. 2000 Apr;37(4):367-80. doi: 10.1159/000020181. Eur Urol. 2000. PMID: 10765065 Review.
-
Finasteride, a Type 2 5alpha-reductase inhibitor, in the treatment of men with androgenetic alopecia.Expert Opin Investig Drugs. 1999 Apr;8(4):403-15. doi: 10.1517/13543784.8.4.403. Expert Opin Investig Drugs. 1999. PMID: 15992088
-
Dihydrotestosterone and the prostate: the scientific rationale for 5alpha-reductase inhibitors in the treatment of benign prostatic hyperplasia.J Urol. 2004 Oct;172(4 Pt 1):1399-403. doi: 10.1097/01.ju.0000139539.94828.29. J Urol. 2004. PMID: 15371854 Review.
Cited by
-
Bone Health Risks Associated with Finasteride and Dutasteride Long-Term Use.World J Mens Health. 2021 Apr;39(2):389-390. doi: 10.5534/wjmh.200138. Epub 2020 Nov 26. World J Mens Health. 2021. PMID: 33663032 Free PMC article. No abstract available.
-
Hair Transplantation in the United States: A Population-based Survey of Female and Male Pattern Baldness.Plast Reconstr Surg Glob Open. 2023 Nov 13;11(11):e5386. doi: 10.1097/GOX.0000000000005386. eCollection 2023 Nov. Plast Reconstr Surg Glob Open. 2023. PMID: 37964923 Free PMC article.
-
Aescin Protects against Experimental Benign Prostatic Hyperplasia and Preserves Prostate Histomorphology in Rats via Suppression of Inflammatory Cytokines and COX-2.Pharmaceuticals (Basel). 2022 Jan 22;15(2):130. doi: 10.3390/ph15020130. Pharmaceuticals (Basel). 2022. PMID: 35215244 Free PMC article.
-
Efficacy and Tolerability of 6-Month Treatment with Tamsulosin Plus the Hexanic Extract of Serenoa repens versus Tamsulosin Plus 5-Alpha-Reductase Inhibitors for Moderate-to-Severe LUTS-BPH Patients: Results of a Paired Matched Clinical Study.J Clin Med. 2022 Jun 22;11(13):3615. doi: 10.3390/jcm11133615. J Clin Med. 2022. PMID: 35806900 Free PMC article.
-
Role of Glucocorticoids in Metabolic Dysfunction-Associated Steatotic Liver Disease.Curr Obes Rep. 2024 Jun;13(2):242-255. doi: 10.1007/s13679-024-00556-1. Epub 2024 Mar 8. Curr Obes Rep. 2024. PMID: 38459229 Free PMC article. Review.
References
-
- Traish AM, Melcangi RC, Bortolato M, Garcia-Segura LM, Zitzmann M. Adverse effects of 5α-reductase inhibitors: What do we know, don't know, and need to know? Rev Endocr Metab Disord. 2015;16:177–198. - PubMed
-
- Traish AM. The post-finasteride syndrome: clinical manifestation of drug-induced epigenetics due to endocrine disruption. Curr Sex Health Rep. 2018;10:88–103.
-
- Traish AM. 5α-reductases in human physiology: an unfolding story. Endocr Pract. 2012;18:965–975. - PubMed
-
- Traish AM, Guay AT, Zitzmann M. 5α-Reductase inhibitors alter steroid metabolism and may contribute to insulin resistance, diabetes, metabolic syndrome and vascular disease: a medical hypothesis. Horm Mol Biol Clin Investig. 2014;20:73–80. - PubMed
-
- Traish AM. Negative impact of testosterone deficiency and 5α-reductase inhibitors therapy on metabolic and sexual function in men. Adv Exp Med Biol. 2017;1043:473–526. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous